Marksans Pharma Limited

NSEI:MARKSANS Rapporto sulle azioni

Cap. di mercato: ₹99.8b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Marksans Pharma Dividendo

Dividendo criteri di controllo 3/6

Marksans Pharma è una società che paga dividendi con un rendimento attuale di 0.27% ben coperto dagli utili. La prossima data di pagamento è il 5th October, 2024 con una data di stacco della cedola di 17th September, 2024.

Informazioni chiave

0.3%

Rendimento del dividendo

9%

Rapporto di remunerazione

Rendimento medio del settore0.7%
Prossima data di pagamento dei dividendi05 Oct 24
Data di stacco del dividendo17 Sep 24
Dividendo per azione₹0.600
Utile per azione₹7.37
Previsione del rendimento del dividendo a 3 anni1.5%

Aggiornamenti recenti sui dividendi

Recent updates

Marksans Pharma Limited (NSE:MARKSANS) Stock Rockets 26% But Many Are Still Ignoring The Company

Jul 28
Marksans Pharma Limited (NSE:MARKSANS) Stock Rockets 26% But Many Are Still Ignoring The Company

Solid Earnings May Not Tell The Whole Story For Marksans Pharma (NSE:MARKSANS)

Jun 07
Solid Earnings May Not Tell The Whole Story For Marksans Pharma (NSE:MARKSANS)

Does Marksans Pharma (NSE:MARKSANS) Deserve A Spot On Your Watchlist?

May 31
Does Marksans Pharma (NSE:MARKSANS) Deserve A Spot On Your Watchlist?

Sentiment Still Eluding Marksans Pharma Limited (NSE:MARKSANS)

Feb 16
Sentiment Still Eluding Marksans Pharma Limited (NSE:MARKSANS)

Here's Why Marksans Pharma (NSE:MARKSANS) Has Caught The Eye Of Investors

Jan 26
Here's Why Marksans Pharma (NSE:MARKSANS) Has Caught The Eye Of Investors

We Think Marksans Pharma (NSE:MARKSANS) Can Manage Its Debt With Ease

Dec 02
We Think Marksans Pharma (NSE:MARKSANS) Can Manage Its Debt With Ease

Marksans Pharma (NSE:MARKSANS) Seems To Use Debt Quite Sensibly

Jun 21
Marksans Pharma (NSE:MARKSANS) Seems To Use Debt Quite Sensibly

Robust Earnings May Not Tell The Whole Story For Marksans Pharma (NSE:MARKSANS)

Nov 17
Robust Earnings May Not Tell The Whole Story For Marksans Pharma (NSE:MARKSANS)

This Is The Reason Why We Think Marksans Pharma Limited's (NSE:MARKSANS) CEO Deserves A Bump Up To Their Compensation

Sep 16
This Is The Reason Why We Think Marksans Pharma Limited's (NSE:MARKSANS) CEO Deserves A Bump Up To Their Compensation

Marksans Pharma (NSE:MARKSANS) Is Increasing Its Dividend To ₹0.25

Sep 01
Marksans Pharma (NSE:MARKSANS) Is Increasing Its Dividend To ₹0.25

Marksans Pharma (NSE:MARKSANS) Could Easily Take On More Debt

Jun 14
Marksans Pharma (NSE:MARKSANS) Could Easily Take On More Debt

Is Now The Time To Put Marksans Pharma (NSE:MARKSANS) On Your Watchlist?

May 27
Is Now The Time To Put Marksans Pharma (NSE:MARKSANS) On Your Watchlist?

Is Marksans Pharma (NSE:MARKSANS) A Risky Investment?

Feb 19
Is Marksans Pharma (NSE:MARKSANS) A Risky Investment?

Marksans Pharma Limited's (NSE:MARKSANS) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Feb 04
Marksans Pharma Limited's (NSE:MARKSANS) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Here's Why We Think Marksans Pharma (NSE:MARKSANS) Is Well Worth Watching

Jan 20
Here's Why We Think Marksans Pharma (NSE:MARKSANS) Is Well Worth Watching

Do Institutions Own Marksans Pharma Limited (NSE:MARKSANS) Shares?

Jan 05
Do Institutions Own Marksans Pharma Limited (NSE:MARKSANS) Shares?

Shareholders Are Thrilled That The Marksans Pharma (NSE:MARKSANS) Share Price Increased 250%

Dec 21
Shareholders Are Thrilled That The Marksans Pharma (NSE:MARKSANS) Share Price Increased 250%

What Can We Conclude About Marksans Pharma's (NSE:MARKSANS) CEO Pay?

Dec 06
What Can We Conclude About Marksans Pharma's (NSE:MARKSANS) CEO Pay?

These 4 Measures Indicate That Marksans Pharma (NSE:MARKSANS) Is Using Debt Safely

Nov 19
These 4 Measures Indicate That Marksans Pharma (NSE:MARKSANS) Is Using Debt Safely

Marksans Pharma Limited's (NSE:MARKSANS) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Nov 04
Marksans Pharma Limited's (NSE:MARKSANS) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

If You Like EPS Growth Then Check Out Marksans Pharma (NSE:MARKSANS) Before It's Too Late

Oct 20
If You Like EPS Growth Then Check Out Marksans Pharma (NSE:MARKSANS) Before It's Too Late

Is Marksans Pharma Limited's (NSE:MARKSANS) Shareholder Ownership Skewed Towards Insiders?

Oct 05
Is Marksans Pharma Limited's (NSE:MARKSANS) Shareholder Ownership Skewed Towards Insiders?

If You Had Bought Marksans Pharma (NSE:MARKSANS) Shares A Year Ago You'd Have Earned273% Returns

Sep 20
If You Had Bought Marksans Pharma (NSE:MARKSANS) Shares A Year Ago You'd Have Earned273% Returns

Prossimo pagamento dei dividendi

OggiAug 20 2024Data di stacco del dividendoSep 17 2024Data di pagamento dei dividendiOct 05 202418 days da Ex DividendoAcquistare nel prossimo 27 days per ricevere il dividendo in arrivo

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: I pagamenti dei dividendi di MARKSANS sono stati volatili negli ultimi 10 anni.

Dividendo in crescita: I pagamenti dei dividendi di MARKSANS sono aumentati negli ultimi 10 anni.


Rendimento dei dividendi rispetto al mercato

Marksans Pharma Rendimento dei dividendi rispetto al mercato
Come si colloca il rendimento da dividendo di MARKSANS rispetto al mercato?
SegmentoRendimento dei dividendi
Azienda (MARKSANS)0.3%
Fondo del 25% del mercato (IN)0.3%
Top 25% del mercato (IN)1.1%
Media del settore (Pharmaceuticals)0.7%
Previsione dell'analista in 3 anni (MARKSANS)1.5%

Dividendo notevole: Il dividendo di MARKSANS ( 0.27% ) è più alto rispetto al 25% inferiore dei pagatori di dividendi nel mercato Indian ( 0.25% ).

Dividendo elevato: Il dividendo di MARKSANS ( 0.27% ) è basso rispetto al 25% dei maggiori pagatori di dividendi nel mercato Indian ( 1.08%.


Distribuzione degli utili agli azionisti

Copertura degli utili: Grazie al suo basso payout ratio ( 8.7% ), i pagamenti dei dividendi di MARKSANS sono completamente coperti dagli utili.


Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Con il suo elevato cash payout ratio ( 126.1% ), i pagamenti dei dividendi di MARKSANS non sono ben coperti dai flussi di cassa.


Scoprire le società che pagano dividendi forti